YANG Qin
Department of Pharmacy, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, ChinaDU Bingxin
Department of Pharmacy, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, ChinaYANG Yeying
Department of Pharmacy, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, ChinaLI Rui
Department of Pharmacy, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, ChinaTIAN Jinwei
Heilongjiang Provincial Key Laboratory of Panvascular Disease, Harbin, Heilongjiang 150086, China;Department of Cardiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, ChinaLIU Huibin
Department of Pharmacy, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China;Heilongjiang Provincial Key Laboratory of Panvascular Disease, Harbin, Heilongjiang 150086, China1.Department of Pharmacy, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China;2.Heilongjiang Provincial Key Laboratory of Panvascular Disease, Harbin, Heilongjiang 150086, China;3.Department of Cardiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China)
R54
YANG Qin, DU Bingxin, YANG Yeying, LI Rui, TIAN Jinwei, LIU Huibin. Research progress and current status of circular RNA in heart failure[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2024,32(9):737-746.
Copy